ClariVest Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $559K | Hold |
8,164
| – | – | 0.06% | 343 |
|
|
2024
Q2 | $559K | Buy |
8,164
+3,194
| +64% | +$219K | 0.06% | 343 |
|
|
2024
Q1 | $344K | Buy |
+4,970
| New | +$344K | 0.04% | 369 |
|
|
2022
Q3 | – | Sell |
-7,633
| Closed | -$436K | – | 768 |
|
|
2022
Q2 | $436K | Hold |
7,633
| – | – | 0.02% | 393 |
|
|
2022
Q1 | $467K | Buy |
+7,633
| New | +$467K | 0.02% | 397 |
|